What’s Driving Growth in the Vasodilators Market? Insights into Key Trends and Opportunities
Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the vasodilators market?
The market size of vasodilators has seen a strong upward trend in the past few years. Projected growth for this market is expected to increase from $6.4 billion in 2024 to $6.83 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historic period include heightened awareness and diagnosis, the effect of government initiatives and healthcare policies, an increase in health consciousness among the populace, progress in gene therapy, and the expanding use of artificial intelligence.
What will be the vasodilators market size in the future?
The market size for vasodilators is set to witness robust expansion in the coming years, with a projection of $8.75 billion by the year 2029, following a compound annual growth rate (CAGR) of 6.4%. Several factors contribute to this growth projected during the forecast period, including increased cases of hypertension and cardiovascular diseases, rising need for advanced cardiac disease medical technology, an aging global population, increased frequency of diabetes and hypertension, and the growing significance of individualized treatment. Noteworthy trends for the forecast duration encompass strategic consolidations and acquisitions, a noticeable transition towards outpatient care and home-based healthcare, innovations in product development, advancements in technology, and the growth of healthcare infrastructure.
Get your vasodilators market report here!
https://www.thebusinessresearchcompany.com/report/vasodilators-global-market-report
What main drivers are fueling expansion in the vasodilators market?
An increase in cardiovascular diseases is predicted to boost the vasodilators market’s growth. These include conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke, which are typically related to hypertension and other risk factors. Factors such as inactive lifestyles, unhealthy eating habits, obesity, tobacco usage, and aging population contribute to the rise in cardiovascular diseases. Vasodilators, which relax blood vessels, lower blood pressure, and enhance blood flow, are used in treating cardiovascular diseases. For example, the Centers for Disease Control and Prevention reported that heart disease accounted for one in every five deaths and took 702,880 lives in 2022. Each year, around 805,000 people in the United States suffer a heart attack, with 605,000 experiencing their first and 200,000 having recurring attacks. Hence, the increased occurrence of cardiovascular diseases is driving the vasodilators market.
Underpinning the Growth of Vasodilator Market: Sedentary Lifestyles
What key areas define the segmentation of the global vasodilators market?
The vasodilators market covered in this report is segmented –
1) By Type: Arterial Dilators, Venous Dilators, Mixed Dilators
2) By Drugs: Nitroglycerin, Alprostadil, Minoxidil, Sorbitrate, Other Drugs
3) By Indication: Hypertension, Angina, Heart Failure, Other Indications
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End User: Hospitals, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Arterial Dilators: Calcium Channel Blockers, Nitric Oxide Donors, Potassium Channel Activators
2) By Venous Dilators: Nitrates, Nitrites, Phosphodiesterase Inhibitors (PDE5 Inhibitors)
3) By Mixed Dilators: Alpha-Adrenergic Antagonists, Angiotensin II Receptor Blockers (ARBs), ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16565&type=smp
What are the top market players propelling the growth of the vasodilators industry?
Major companies operating in the vasodilators market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., AstraZeneca, Mayo Foundation for Medical Education and Research (MFMER), Boehringer Ingelheim International GmbH, Bayer AG, Viatris Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen
What are the key trends shaping the future of the vasodilators market?
Key players in the vasodilators market are striving to develop innovative products, such as soluble guanylate cyclase (sGC) stimulators, to achieve a competitive advantage in the industry. Soluble guanylate cyclase (sGC) is an enzyme present in cells, predominantly in blood vessel-lining smooth muscle cells. This enzyme, when triggered, transforms guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP), resulting in vasodilation and increased blood circulation. For instance, in September 2022, Vericiguat (Verquvo), a soluble guanylate cyclase (sGC) activator for adults dealing with symptomatic chronic heart failure was introduced by the Germany-based pharmaceutical and biotech firm, Bayer AG. Unlike existing treatments, this drug aims at an untouched pathway, reducing the risks of cardiovascular mortality and hospitalization.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16565
Which regions are most influential in expanding the vasodilators market?
North America was the largest region in the vasodilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vasodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Lymphocyte Modulator Global Market Report 2024
Mechanical Ventilator Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/mechanical-ventilator-global-market-report
Ambulatory IV infusion Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
